Perspective Therapeutics, Inc. (CATX)
USD 1.87
(0.81%)
USD 1.87
(0.81%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -0.10 USD | -98.41% |
| 2021 | -0.05 USD | -64.17% |
| 2020 | -0.03 USD | 36.57% |
| 2019 | -0.05 USD | 33.06% |
| 2018 | -0.07 USD | 39.75% |
| 2017 | -0.12 USD | -9.09% |
| 2016 | -0.11 USD | -28.5% |
| 2015 | -0.09 USD | -27.57% |
| 2014 | -0.07 USD | 52.07% |
| 2013 | -0.14 USD | -27.27% |
| 2012 | -0.11 USD | 8.33% |
| 2011 | -0.12 USD | -9.09% |
| 2010 | -0.11 USD | 38.89% |
| 2009 | -0.18 USD | 33.33% |
| 2008 | -0.27 USD | 27.03% |
| 2007 | -0.37 USD | 31.48% |
| 2006 | -0.54 USD | 20.59% |
| 2005 | -0.68 USD | 0.0% |
| 2003 | 0.03 USD | 140.16% |
| 2002 | -0.07 USD | 58.5% |
| 2001 | -0.18 USD | -130.0% |
| 2000 | 0.60 USD | 400.0% |
| 1999 | -0.20 USD | -103.7% |
| 1998 | 5.41 USD | 1388.1% |
| 1997 | -0.42 USD | 67.44% |
| 1996 | -1.29 USD | 80.54% |
| 1995 | -6.63 USD | -102.75% |
| 1994 | -3.27 USD | -115.13% |
| 1993 | -1.52 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q1 | -0.04 USD | 7.05% |
| 2022 Q3 | -0.00 USD | 89.68% |
| 2022 Q1 | -0.03 USD | -94.37% |
| 2022 Q2 | -0.02 USD | 43.84% |
| 2022 FY | - USD | -98.41% |
| 2022 Q4 | -0.04 USD | -2381.25% |
| 2021 Q3 | -0.01 USD | 24.78% |
| 2021 Q1 | -0.02 USD | -110.67% |
| 2021 FY | - USD | -64.17% |
| 2021 Q4 | -0.01 USD | -67.06% |
| 2021 Q2 | -0.01 USD | 28.48% |
| 2020 Q3 | -0.01 USD | 41.9% |
| 2020 Q2 | -0.01 USD | -1.94% |
| 2020 Q1 | -0.01 USD | 41.14% |
| 2020 FY | - USD | 36.57% |
| 2020 Q4 | -0.01 USD | -22.95% |
| 2019 Q3 | -0.01 USD | 39.1% |
| 2019 FY | - USD | 33.06% |
| 2019 Q1 | -0.01 USD | 25.77% |
| 2019 Q2 | -0.01 USD | -9.92% |
| 2019 Q4 | -0.02 USD | -116.05% |
| 2018 Q1 | -0.02 USD | 46.35% |
| 2018 Q2 | -0.02 USD | 7.89% |
| 2018 Q3 | -0.02 USD | 20.48% |
| 2018 Q4 | -0.02 USD | 2.4% |
| 2018 FY | - USD | 39.75% |
| 2017 Q3 | -0.02 USD | 9.02% |
| 2017 FY | - USD | -9.09% |
| 2017 Q2 | -0.03 USD | 5.34% |
| 2017 Q1 | -0.03 USD | 16.62% |
| 2017 Q4 | -0.04 USD | -75.62% |
| 2016 Q1 | -0.03 USD | -26.51% |
| 2016 FY | - USD | -28.5% |
| 2016 Q4 | -0.03 USD | -36.44% |
| 2016 Q3 | -0.02 USD | 6.44% |
| 2016 Q2 | -0.03 USD | 2.94% |
| 2015 FY | - USD | -27.57% |
| 2015 Q4 | -0.02 USD | 0.92% |
| 2015 Q3 | -0.02 USD | 8.82% |
| 2015 Q2 | -0.02 USD | -28.65% |
| 2015 Q1 | -0.02 USD | 1.6% |
| 2014 Q2 | -0.02 USD | -15.38% |
| 2014 Q1 | -0.01 USD | 53.27% |
| 2014 Q4 | -0.02 USD | -8.05% |
| 2014 FY | - USD | 52.07% |
| 2014 Q3 | -0.02 USD | -5.45% |
| 2013 Q2 | -0.02 USD | 31.92% |
| 2013 FY | - USD | -27.27% |
| 2013 Q1 | -0.04 USD | -36.68% |
| 2013 Q4 | -0.03 USD | 37.55% |
| 2013 Q3 | -0.05 USD | -103.32% |
| 2012 Q1 | -0.03 USD | 15.8% |
| 2012 FY | - USD | 8.33% |
| 2012 Q3 | -0.02 USD | 38.02% |
| 2012 Q2 | -0.03 USD | -13.99% |
| 2012 Q4 | -0.03 USD | -25.12% |
| 2011 FY | - USD | -9.09% |
| 2011 Q3 | -0.02 USD | 14.09% |
| 2011 Q4 | -0.03 USD | -84.13% |
| 2011 Q1 | -0.04 USD | -67.07% |
| 2011 Q2 | -0.02 USD | 47.12% |
| 2010 Q1 | -0.04 USD | 12.5% |
| 2010 FY | - USD | 38.89% |
| 2010 Q2 | -0.01 USD | 75.93% |
| 2010 Q3 | -0.04 USD | -335.16% |
| 2010 Q4 | -0.02 USD | 37.12% |
| 2009 FY | - USD | 33.33% |
| 2009 Q1 | -0.04 USD | 27.79% |
| 2009 Q3 | -0.05 USD | -15.22% |
| 2009 Q4 | -0.04 USD | 9.43% |
| 2009 Q2 | -0.04 USD | -4.81% |
| 2008 Q2 | -0.07 USD | 8.95% |
| 2008 FY | - USD | 27.03% |
| 2008 Q1 | -0.08 USD | -24.52% |
| 2008 Q4 | -0.05 USD | 15.19% |
| 2008 Q3 | -0.06 USD | 9.41% |
| 2007 Q2 | -0.12 USD | -27.8% |
| 2007 Q1 | -0.09 USD | 21.75% |
| 2007 Q4 | -0.06 USD | 33.19% |
| 2007 FY | - USD | 31.48% |
| 2007 Q3 | -0.09 USD | 21.67% |
| 2006 Q4 | -0.12 USD | 0.0% |
| 2006 Q2 | -0.12 USD | 36.84% |
| 2006 Q1 | -0.19 USD | -18.75% |
| 2006 FY | - USD | 20.59% |
| 2006 Q3 | -0.12 USD | 0.0% |
| 2005 Q3 | -0.11 USD | 35.29% |
| 2005 Q2 | -0.17 USD | 22.73% |
| 2005 Q4 | -0.16 USD | -45.45% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | -0.22 USD | 0.0% |
| 2004 Q2 | -0.00 USD | 11.76% |
| 2004 Q3 | 0.02 USD | 1260.0% |
| 2004 Q1 | -0.00 USD | -13.33% |
| 2003 Q2 | -0.00 USD | 43.75% |
| 2003 FY | - USD | 140.16% |
| 2003 Q3 | -0.00 USD | 29.63% |
| 2003 Q1 | -0.00 USD | 84.42% |
| 2003 Q4 | -0.00 USD | 21.05% |
| 2002 Q3 | -0.05 USD | 23.72% |
| 2002 FY | - USD | 58.5% |
| 2002 Q1 | -0.04 USD | 12.16% |
| 2002 Q2 | -0.06 USD | -62.92% |
| 2002 Q4 | -0.03 USD | 35.29% |
| 2001 Q2 | -0.04 USD | 53.12% |
| 2001 Q3 | -0.05 USD | -23.62% |
| 2001 Q4 | -0.04 USD | 19.11% |
| 2001 Q1 | -0.09 USD | -28.99% |
| 2001 FY | - USD | -130.0% |
| 2000 Q4 | -0.07 USD | -71.26% |
| 2000 Q2 | -0.05 USD | 44.69% |
| 2000 Q1 | -0.08 USD | -108.93% |
| 2000 FY | - USD | 400.0% |
| 2000 Q3 | -0.04 USD | 7.06% |
| 1999 Q3 | -0.04 USD | 0.0% |
| 1999 FY | - USD | -103.7% |
| 1999 Q4 | -0.04 USD | 0.0% |
| 1999 Q1 | -0.08 USD | -63.81% |
| 1999 Q2 | -0.04 USD | 49.94% |
| 1998 Q2 | 5.71 USD | 0.0% |
| 1998 Q3 | -0.04 USD | -100.77% |
| 1998 Q4 | -0.05 USD | -8.14% |
| 1998 FY | - USD | 1388.1% |
| 1997 FY | - USD | 67.44% |
| 1996 FY | - USD | 80.54% |
| 1995 FY | - USD | -102.75% |
| 1994 FY | - USD | -115.13% |
| 1993 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Electromed, Inc. | 0.60 USD | 116.667% |
| Senseonics Holdings, Inc. | -0.11 USD | 9.091% |
| Catheter Precision, Inc. | -12.99 USD | 99.23% |
| Xtant Medical Holdings, Inc. | 0.01 USD | 1918.182% |